TY - JOUR AU - Lee, Rachael Chang AU - Thapa, Bibhusal AU - John, Thomas PY - 2018 TI - LACES and bootstraps: the hunt for prognostic and predictive markers for adjuvant therapy in NSCLC JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - The benefit from adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC) is modest with an overall survival (OS) benefit of only ~5% demonstrated in the Lung Adjuvant Cisplatin Evaluation (LACE) meta-analysis (1). UR - https://tlcr.amegroups.org/article/view/24027